Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M222Revenue $M10.3Net Margin (%)38.6Z-Score17.5
Enterprise Value $M184EPS $-0.6Operating Margin %28.0F-Score5
P/E(ttm))23.8Cash Flow Per Share $1.4Pre-tax Margin (%)38.6Higher ROA y-yY
Price/Book6.110-y EBITDA Growth Rate %0Quick Ratio6.2Cash flow > EarningsN
Price/Sales8.85-y EBITDA Growth Rate %0Current Ratio6.2Lower Leverage y-yY
Price/Cash Flow3.6y-y EBITDA Growth Rate %0ROA % (ttm)21.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)29.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M32.1ROI % (ttm)-25.4Gross Margin Increase y-yN

Gurus Latest Trades with POZN

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
POZNJohn Rogers 2014-12-31 Reduce-0.05%$7.63 - $9.5
($8.62)
$ 7.33-15%Reduce -23.32%1,588,798
POZNJohn Rogers 2014-06-30 Reduce-0.12%$7.69 - $9.6
($8.6)
$ 7.33-15%Reduce -41.14%1,813,164
POZNJohn Rogers 2013-12-31 Reduce-0.07%$5.58 - $9.77
($7.13)
$ 7.333%Reduce -20.01%3,503,586
POZNJohn Rogers 2013-09-30 Add0.1%$5 - $5.92
($5.53)
$ 7.3332%Add 35.67%4,379,824
POZNJohn Rogers 2013-06-30 Add0.2%$4.5 - $5.5
($4.99)
$ 7.3347%Add 311.99%3,228,236
POZNJohn Rogers 2013-03-31 Buy 0.07%$5.01 - $6.41
($5.72)
$ 7.3328%New holding, 783580 sh.783,580
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

POZN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
POZN John Rogers 2014-12-311,588,7984.950.15-23.32%
Premium Most recent portfolio changes are included for Premium Members only!


POZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Thomas Gilda MarieSr. VP, Gen. Cnsl. & Secretary 2015-01-02Sell25,000$7.91-7.33view
PAR INVESTMENT PARTNERS LP10% Owner 2014-12-01Buy500,000$7.5-2.27view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-11-18Sell50,000$9-18.56view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-11-06Sell50,000$9.08-19.27view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-10-21Sell50,000$8.17-10.28view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-10-09Sell50,000$8.12-9.73view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-09-30Sell50,000$7.48-2.01view
McNamara Dennis LEVP, Chief Business Officer 2014-09-15Sell4,275$7.85-6.62view
PLACHETKA JOHN RPresident, CEO and Chairman 2014-09-09Sell50,000$8.24-11.04view
BARNHARDT JOHN EVP, Finance and Administration 2014-08-25Sell4,293$8.25-11.15view

Press Releases about POZN :

    Quarterly/Annual Reports about POZN:

    News about POZN:

    Articles On GuruFocus.com
    Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notice of A Oct 15 2014 
    Weekly Insider Sells Highlight: AR, CSCO, SUTR, POZN, JAH May 27 2014 
    Guru Weekly Real Time Update Jul 12 2013 
    John Rogers Makes 5 Real-Time Increases Jul 11 2013 
    John Rogers' May Commentary - What's Attractive and New Buys Jun 13 2013 
    comment on POZN Nov 13 2012 
    Pozen Inc. Reports Operating Results (10-K) Mar 10 2011 
    Pozen Inc. Reports Operating Results (10-Q) Oct 29 2010 
    Pozen Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Pozen Inc. Reports Operating Results (10-Q) Apr 29 2010 

    More From Other Websites
    Coverage initiated on POZEN by Chardan Capital Markets Feb 18 2015
    POZEN INC /NC Files SEC form 8-K, Other Events Feb 06 2015
    POZEN Announces Issuance of VIMOVO® Related Patent by the United States Patent and Trademark Office Feb 04 2015
    POZEN Announces Issuance of VIMOVO® Related Patent by the United States Patent and Trademark Office Feb 04 2015
    POZEN INC /NC Files SEC form 8-K, Change in Directors or Principal Officers Jan 05 2015
    POZEN INC /NC Files SEC form 8-K, Termination of a Material Definitive Agreement Dec 29 2014
    Equity markets surge...so many stories – where to begin? Dec 17 2014
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pozen, Inc. -... Dec 17 2014
    POZEN Inc. Update on 2nd CRL from the FDA for YOSPRALA Call scheduled for 8:30 am ET today Dec 17 2014
    POZEN INC /NC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 17 2014
    POZEN’s YOSPRALA™ Receives Complete Response Letter from The FDA Dec 17 2014
    POZEN’s YOSPRALA™ Receives Complete Response Letter from The FDA Dec 17 2014
    OPEC's stubborn oil stance Dec 15 2014
    POZN: Pozen Seeking New Partner For Yosprala Dec 01 2014
    POZEN Inc. and Sanofi US Mutually Agree to Terminate U.S. Partnership for PA8140/PA32540 Call... Dec 01 2014
    POZEN Inc. and Sanofi US Mutually Agree to Terminate U.S. Partnership for PA8140/PA32540 Dec 01 2014
    POZEN INC /NC Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial... Dec 01 2014
    POZEN Inc. and Sanofi US Mutually Agree to Terminate U.S. Partnership for PA8140/PA32540 Dec 01 2014
    Geopolitical risk premium gone from oil: Pro Nov 18 2014
    POZEN INC /NC Financials Nov 15 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK